Unitree's 8,000x retail book sets the price every other humanoid program gets measured against

Unitree's Shanghai listing drew retail applications of more than 8,000 times the available book, a record for the STAR Market, with the start of trading due to be announced later on August 14 ^[1][2]. The subscription multiple is a sentiment reading; the number that will actually move other people's fundraising is the grey-market quote of 410 yuan against a 150.8 yuan offer price, reported by Chinese media ^[4].

Work the float arithmetic. Unitree raised 6.1bn yuan, about $905m, for 10% of its enlarged share capital ^[3], which puts the deal price on roughly 61bn yuan, or about $9.05bn post-money ^[1]. At 150.8 yuan that is about 40.5m shares sold and roughly 404.5m outstanding ^[2]. Mark the whole register at 410 yuan and you get about 166bn yuan, near $24.6bn ^[3] - roughly 105bn yuan, or $15.5bn, of value added by markets outside the prospectus ^[7]. The scarcity is structural: a 10% float, and, per the source, an offer small enough that investors who missed allocation are expected to buy on the tape instead ^[3].

Unitree arrives with things its peers cannot all claim. It is described as the world's largest humanoid maker by sales volume, the first general-purpose robotics company to list on the mainland, and already profitable ^[5]. Jack Pearson calls it a turning point for Chinese robotics and says the company reaches public markets with what many humanoid makers lack, scale combined with profit ^[6]. Backers include Tencent, Alibaba and DeepSeek, and founder Wang Xingxing attended an early-2025 meeting between tech entrepreneurs and Xi Jinping ^[7].

That is the repricing problem for everyone else. UBTech and Dobot already trade in Hong Kong, and Leju Robotics and Agitbot are preparing listings ^[13]. They will now be pitched against a comparable set near 166bn yuan ^[3] while, on Pearson's own framing, the profit and volume that justify it are not general to the sector ^[6][5]. Borrowing the multiple without the P&L is the failure mode.

Calibration cuts both ways. Jeff Ko of CoinEx notes Chinese IPOs averaged a 233% first-day return in the first half of 2026 ^[10], which means the 172% grey-market premium is below the average pop rather than above it ^[5][8]. Ko puts Hiive's roughly $62 print at 176% upside to the IPO price and says every market outside the regulated IPO process embeds a substantial scarcity premium ^[9]. Private platforms imply about three times the offer, Hyperliquid and Gate derivatives closer to four ^[8]; the Hyperliquid contract on Trade.xyz was near $90 on the morning of August 14 ^[11], which is about 4.0 times the offer price converted at the deal's own exchange rate ^[6]. A Hangzhou trader, Wen Hao, floated eight times on debut ^[11]. CXMT's Shanghai debut, up more than fivefold on day one, is doing a lot of work on sentiment here ^[12].

The stated risks are unglamorous and unresolved: commercial viability at scale is unproven, mature manufacturing use cases are limited, competition is rising, and US restrictions on Chinese humanoid makers are possible ^[14]. Jeff Mei doubts the sector's long-term prospects justify the current valuation and points to SpaceX trading below its IPO price after listing ^[15].

Watch the first settled price rather than the pop, since as of August 14 no official trading price existed ^[16], and watch whether Leju and Agitbot reset their asks to the new comparable ^[13]. Note also what the material does not contain: nothing on Unitree's component costs or supplier terms. Any read-through to actuator and sensor suppliers is inference until someone publishes an order book.